Clinical Trials Logo

Clinical Trial Summary

This is a phase IV one-arm study aiming at recruiting 50 patients to assess the efficacy of AQ+AS in patients with a positive RDT diagnosis of malaria in Nanoro, Burkina Faso.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01213433
Study type Interventional
Source Centre Muraz
Contact
Status Completed
Phase Phase 4
Start date October 2010
Completion date April 2011

See also
  Status Clinical Trial Phase
Recruiting NCT00540202 - Effectiveness of Oral Quinine and Artemether-Lumefantrine in the Treatment of Uncomplicated Malaria in Ugandan Children Phase 4
Completed NCT02787070 - A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI) Phase 4
Active, not recruiting NCT00406146 - Amodiaquine+Artesunate vs. Artemether-Lumefantrine for Uncomplicated Malaria in Ghanaian Children Phase 3
Completed NCT05192265 - Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine Phase 2/Phase 3
Completed NCT04767191 - Malaria Therapeutic Efficacy Study (TES) Kenya Phase 4
Completed NCT04767217 - Malaria Therapeutic Efficacy Study, Rwanda Phase 4
Completed NCT06036030 - Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua Phase 2
Recruiting NCT06064591 - Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX
Completed NCT06300970 - Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia Phase 4
Completed NCT00845533 - Pharmacokinetics of Dihydroartemisinin-Piperaquine in the Treatment of Uncomplicated Malaria in Children in Burkina Faso Phase 4
Not yet recruiting NCT05911828 - A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers Phase 1
Completed NCT03387631 - Efficacy And Safety Of AL For The Treatment Of Uncomplicated Falciparum Malaria In Mainland Tanzania N/A
Completed NCT00868465 - Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy (TRANSACT) N/A
Completed NCT00460369 - Treatment of Uncomplicated Malaria in Benin N/A
Completed NCT00459615 - Phase II Dose Ranging Study of Artesunate Phase 2